Results 251 to 260 of about 305,984 (384)

Correction: De novo and inherited variants in coding and regulatory regions in genetic cardiomyopathies. [PDF]

Hum Genomics
Vadgama N, Ameen M, Sundaram L, Gaddam S, Gifford C, Nasir J, Karakikes I, Genomics England Research Consortium.   +7 more
europepmc   +1 more source

Takotsubo Cardiomyopathy

Canadian Medical Education Journal, 2022
openaire   +3 more sources

Takotsubo Cardiomyopathy [PDF]

Texas Heart Institute Journal, 2014
Ambar A, Andrade, Raymond F, Stainback
openaire   +2 more sources

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Effect of scar distribution on transmural and planar repolarization gradients and dispersion in non-ischemic cardiomyopathies with ventricular arrhythmias. [PDF]

Europace
Tonko JB, Cabrera-Borrego E, Sánchez-Millán P, Jiménez-Jáimez J, Chow A, Lambiase PD.   +5 more
europepmc   +1 more source

Low MMP-8/TIMP-1 reflects left ventricle impairment in takotsubo cardiomyopathy and high TIMP-1 may help to differentiate it from acute coronary syndrome

, 2017
Olavi Parkkonen, Mikko T. Nieminen, Paula Vesterinen, Taina Tervahartiala, Markus Perola, Veikko Salomaa, Pekka Jousilahti, Timo Sorsa, Pirkko J. Pussinen, Juha Sinisalo   +9 more
openalex   +2 more sources

Verapamil: a cause of sudden death in a patient with hypertrophic cardiomyopathy. [PDF]

, 1984
B Perrot, Nicolas Danchin, A. Terrier De La Chaise   +2 more
openalex   +1 more source

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

ESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies, Svenja Ney, Ingrid Kindermann, Yvonne Bewarder, Angela Zimmer, Fabian Knebel, Katrin Hahn, Sebastian Spethmann, Peter Luedike, Lars Michel, Tienush Rassaf, Maria Papathanasiou, Stefan Störk, Vladimir Cejka, Amin Polzin, Fabian Voss, Malte Kelm, Bernhard Unsöld, Christine Meindl, Michael Paulus, Ali Yilmaz, Bishwas Chamling, Caroline Morbach, Roman Pfister   +23 more
wiley   +1 more source

Exercise Rehabilitation for Heart Failure and Associated Cardiomyopathies. [PDF]

Curr Cardiol Rep
Stahl ME, Weeldreyer NR, MacNamara JP, Lozano PFR, Allen JD.   +4 more
europepmc   +1 more source

EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication.

Europace, 2016
A. Goette, J. Kalman, L. Aguinaga, J. Akar, J. Cabrera, Shih‐Ann Chen, S. Chugh, D. Corradi, A. d'Avila, D. Dobrev, G. Fenelon, M. Gonzalez, S. Hatem, Robert H. Helm, G. Hindricks, S. Ho, B. Hoit, J. Jalife, Young-Hoon Kim, G. Lip, Changsheng Ma, G. Marcus, K. Murray, A. Nogami, P. Sanders, W. Uribe, D. V. Van Wagoner, S. Nattel   +27 more
semanticscholar   +1 more source